You are here

m6A-modified RNA in CSCs

A recent STEM CELLS review article from Zhonghua Ma and Jiafu Ji (Peking University Cancer Hospital and Institute, Beijing, China) provides a snapshot of the current advances relating to the role of the N6‐methyladenosine (m6A) RNA modification in cancer stem cells (CSCs) and cancer biology. The authors note that identifying those mechanisms involving m6A in CSCs may lead to the development of new and improved cancer therapeutics.